Val279Phe variant of Lp-PLA2 is a risk factor for a subpopulation of Indonesia patients with acute myocardial infarction

about

Val279Phe variant of Lp-PLA2 is a risk factor for a subpopulation of Indonesia patients with acute myocardial infarction

Item

http://www.wikidata.org/entity/Q57219255

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2016

@uk

name

Val279Phe variant of Lp-PLA2 i ...... th acute myocardial infarction

@en

Val279Phe variant of Lp-PLA2 i ...... th acute myocardial infarction

@nl

type

Item

label

Val279Phe variant of Lp-PLA2 i ...... th acute myocardial infarction

@en

Val279Phe variant of Lp-PLA2 i ...... th acute myocardial infarction

@nl

prefLabel

Val279Phe variant of Lp-PLA2 i ...... th acute myocardial infarction

@en

Val279Phe variant of Lp-PLA2 i ...... th acute myocardial infarction

@nl

P1476

Val279Phe variant of Lp-PLA2 i ...... th acute myocardial infarction

@en

P2093

Andi Wahjono Adi

http://www.w3.org/2001/XMLSchema#string

Dadang Hendrawan

http://www.w3.org/2001/XMLSchema#string

Jayarani Fatimah Putri

http://www.w3.org/2001/XMLSchema#string

Mifetika Lukitasari

http://www.w3.org/2001/XMLSchema#string

Miryanti Cahyaningtias

http://www.w3.org/2001/XMLSchema#string

Mohammad Saifur Rohman

http://www.w3.org/2001/XMLSchema#string

Rina Yuda

http://www.w3.org/2001/XMLSchema#string

Rusdianto

http://www.w3.org/2001/XMLSchema#string

Widodo

http://www.w3.org/2001/XMLSchema#string

Yanna Indrayana

http://www.w3.org/2001/XMLSchema#string

P2860

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a review

Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.

Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature

Racial variation in lipoprotein-associated phospholipase A₂ in older adults.

Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.

P304

289-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.GENDIS.2016.08.002

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30258899

http://www.w3.org/2001/XMLSchema#string

P921

Aat atak

P932

6147166

http://www.w3.org/2001/XMLSchema#string